Turn Therapeutics to file for clearance of antimicrobial wound matrix
Advanced wound care specialist Turn Therapeutics has announced it has received positive data for its absorbent, antimicrobial regenerative wound matrix called Flex Antimicrobial.
The material employs a cold mixing process to fuse the company’s US Food and Drug Administration-cleared Hexagen antimicrobial formula with an FDA-cleared regenerative collagen powder in a 20%/80% ratio.
For the full story, see the February 2021 edition of Medical Textiles.